These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16768781)

  • 1. Complete axillary dissection: a technique that still has relevance in contemporary management of breast cancer.
    Ung O; Tan M; Chua B; Barraclough B
    ANZ J Surg; 2006 Jun; 76(6):518-21. PubMed ID: 16768781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radical axillary dissection in sentinel lymph node biopsy era: it's still a considerable technique in breast cancer management?
    Sanguinetti A; Catania A; Docimo G; Avenia N
    G Chir; 2010; 31(6-7):344-6. PubMed ID: 20646390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized clinical trial comparing level II and level III axillary node dissection in addition to mastectomy for breast cancer.
    Tominaga T; Takashima S; Danno M
    Br J Surg; 2004 Jan; 91(1):38-43. PubMed ID: 14716791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axillary dissection: when and how radical?
    Morrow M
    Semin Surg Oncol; 1996; 12(5):321-7. PubMed ID: 8873319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach.
    Samphao S; Eremin JM; El-Sheemy M; Eremin O
    Ann Surg Oncol; 2008 May; 15(5):1282-96. PubMed ID: 18330650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE
    Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpectoral approach to dissection of the axillary apex: an elegant and effective approach.
    Pai A; Gupta P; Raina S; Nadkarni MS; Parmar V; Badwe RA
    J Surg Oncol; 2006 Sep; 94(3):252-4. PubMed ID: 16900515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axillary lymph node clearance: overcoming the technical difficulties.
    Hussien M; Spence RA
    Breast; 2004 Apr; 13(2):133-8. PubMed ID: 15019694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years.
    Domènech A; Benitez A; Bajén MT; Pla MJ; Gil M; Martín-Comín J
    Oncology; 2007; 72(1-2):27-32. PubMed ID: 17998787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resectable breast cancer: axillary dissection sparing pectoralis muscles and nerves.
    Muscolino G; Leo E; Sacchini V; Bedini AV; Luini A
    Eur J Surg Oncol; 1988 Oct; 14(5):429-33. PubMed ID: 3181447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
    Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
    Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preservation of minor pectoralis muscle in axillary dissection for breast cancer: functional and cosmetic evaluation.
    Merson M; Pirovano C; Balzarini A; Luini A; Biasi S; Galimberti V; Genitoni V; Muscolino G; Veronesi P
    Eur J Surg Oncol; 1992 Jun; 18(3):215-8. PubMed ID: 1607030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
    Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
    Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary management after sentinel lymph node biopsy in breast cancer patients.
    Rivers A; Hansen N
    Surg Clin North Am; 2007 Apr; 87(2):365-77, ix. PubMed ID: 17498532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and outcomes of isolated axillary node recurrence in breast cancer.
    Konkin DE; Tyldesley S; Kennecke H; Speers CH; Olivotto IA; Davis N
    Arch Surg; 2006 Sep; 141(9):867-72; discussion 872-4. PubMed ID: 16983030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medial pectoral pedicle: a critical landmark in axillary dissection.
    Nadkarni MS; Raina S; Badwe RA
    ANZ J Surg; 2006 Jul; 76(7):652-4. PubMed ID: 16813636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer.
    Crane-Okada R; Wascher RA; Elashoff D; Giuliano AE
    Ann Surg Oncol; 2008 Jul; 15(7):1996-2005. PubMed ID: 18415650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal access breast surgery: a single breast incision for breast conservation surgery and sentinel lymph node biopsy.
    Spillane AJ; Brennan ME
    Eur J Surg Oncol; 2009 Apr; 35(4):380-6. PubMed ID: 18757165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.